PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.97%
Net income growth above 1.5x MRVL's 0.46%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.60%
Both reduce yoy D&A, with MRVL at -5.96%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
211.24%
Some yoy growth while MRVL is negative at -74.39%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
2.26%
SBC growth while MRVL is negative at -11.99%. John Neff would see competitor possibly controlling share issuance more tightly.
-70.14%
Both reduce yoy usage, with MRVL at -173.70%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-773.73%
Both yoy AR lines negative, with MRVL at -344.91%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-7.05%
Negative yoy inventory while MRVL is 4083.91%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-26.15%
Negative yoy AP while MRVL is 113.40%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
71.54%
Lower 'other working capital' growth vs. MRVL's 403.47%. David Dodd would see fewer unexpected short-term demands on cash.
170.05%
Well above MRVL's 31.89%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-107.79%
Both yoy CFO lines are negative, with MRVL at -9.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
24.34%
CapEx growth well above MRVL's 33.54%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
41.71%
Purchases well above MRVL's 50.56%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
45.70%
1.25-1.5x MRVL's 38.31%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
No Data
No Data available this quarter, please select a different quarter.
79.79%
Investing outflow well above MRVL's 80.97%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-173.79%
Both yoy lines negative, with MRVL at -1.95%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
37.58%
We slightly raise equity while MRVL is negative at -36.68%. John Neff sees competitor possibly preserving share count or buying back shares.
-100.00%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.